Latest filing published 10 May 2022 for Mimedx Group, INC., €13k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Mark Graves: trading record in brief
Mark Graves, listed as senior executive, appears in our data through filings on Mimedx Group, Inc. shares, published by SEC (Form 4). Between 26 April 2020 and 9 May 2022, the trades on record add up to 10 filings.
Every open-market trade on record is a sale: 3 sales worth €45k. Besides market trades, the filings include 7 share grants. In 2022 alone, the filings show no purchases and 3 sales.
Most recently, on 10 May 2022, the filings show an open-market sale worth €13k in Mimedx Group, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mark Graves
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,891 shares@ US$3.50084.8% of flowCommon StockSEC:0001803893-22-000004:0
- 48,485 shares@ US$4.6277.5% of flowCommon StockSEC:0001376339-22-000043:0
- 3,234 shares@ US$4.8595.4% of flowCommon StockSEC:0001376339-22-000024:0
- 4,525 shares@ US$4.3186.5% of flowCommon StockSEC:0001803893-22-000002:0
- 1,505 shares@ US$12.075.8% of flowCommon StockSEC:0001376339-21-000089:0
5 of 5 declarations
